Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004

Clinical Microbiology and Infection

Volumn 14, Issue 11, 2008, Pages 1002-1009

  Lamagni, Theresa L ^a   Neal, S ^a   Keshishian, C ^a   Hope, V ^a   George, R ^a   Duckworth, G ^a   Vuopio Varkila, J ^b   Efstratiou, A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Bacteraemia; Epidemiology; Intravenous; Streptococcus pyogenes; Substance misuse; UK

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ENDOCARDITIS; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PERICARDITIS; POPULATION RISK; PRIORITY JOURNAL; SEASONAL VARIATION; SEX RATIO; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; UNITED KINGDOM;

STREPTOCOCCUS PYOGENES;

EID: 56849114285     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02076.x     Document Type: Article

References (23)

1. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med 2005; 353: 1945-1954.
2. Jones JA, Salmon JE, Djuretic T et al. An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol 2002; 51: 978-984.
3. Hahné SJ, White JM, Crowcroft NS et al. Tetanus in injecting drug users, United Kingdom. Emerg Infect Dis 2006; 12: 709-710.
4. Akbulut D, Dennis J, Gent M et al. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill 2005; 10: 172-174.
5. HPA. Methicillin-resistant Staphylococcus aureus (MRSA) in injecting drug users. Commun Dis Rep CDR Wkly (serial online) 2003; 13 (news).
6. Efstratiou A, Emery M, Lamagni TL, Tanna A, Warner M, George RC. Increasing incidence of group.A streptococcal infections amongst injecting drug users in England and Wales. J Med Microbiol 2003; 52: 525-526.
7. Lamagni TL, Neal S, Keshishian C et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008; 14: 201-209.
8. Lamagni TL, Darenberg J, Luca-Harari B et al. The epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46: 2359-2367.
9. PHLS. Enhanced surveillance of invasive group.A streptococcal infections. Commun Dis Rep CDR Wkly (serial online) 2002; 12: (news).
10. The Working Group on Severe Streptococcal Infections. Defining the group.A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993; 269: 390-391.
11. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C, Strep-EURO. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 2005; 10: 179-184.
12. Sierra JM, Sanchez F, Castro P et al. Group.A streptococcal infections in injection drug users in Barcelona, Spain: Epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003. Medicine (Baltimore) 2006; 85: 139-146.
13. Navarro VJ, Axelrod PI, Pinover W, Hockfield HS, Kostman JR. A comparison of Streptococcus pyogenes (group.A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use. Arch Intern Med 1993; 153: 2679-2684.
14. Curtis SJ, Tanna A, Russell HH et al. Invasive group.A streptococcal infection in injecting drug users and non-drug users in a single UK city. J Infect 2007; 54: 422-426.
15. Cartwright K, Logan M, McNulty C et al. A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire. Epidemiol Infect 1995; 115: 387-397.
16. Barnham M, Weightman N, Chapman S, Efstratiou A, George RC, Stanley J. Two clusters of invasive Streptococcus pyogenes infection in England. Adv Exp Med Biol 1997; 418: 67-69.
17. El Bouri KW, Lewis AM, Okeahialam CA, Wright D, Tanna A, Joynson DH. A community outbreak of invasive and non-invasive group.A beta-haemolytic streptococcal disease in a town in South Wales. Epidemiol Infect 1998; 121: 515-521.
18. Tanna A, Emery M, Dhami C, Arnold E, Efstratiou A. Molecular characterization of clinical isolates of M non-typable group.A streptococci from invasive disease cases. J Med Microbiol 2006; 55: 1419-1423.
19. Office for National Statistics. Deaths related to drug poisoning, England and Wales, 1993-2005. Health Stat Q 2007 (Spring); 82-86.
20. The Centre for Drug Misuse Research. Estimates of the prevalence of opiate use and/or crack cocaine use (2004/05). National Treatment Agency for Substance Misuse 2007. Available at: http://www.nta.nhs.uk/areas/ facts_and_figures/prevalence_data/default.aspx (last accessed 14 November 2007).
21. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, and CRDHB. Shooting up: infections among injecting drug users in the United Kingdom 2006. London: Health Protection Agency, 2007.
22. McLauchlin J, Mithani V, Bolton FJ et al. An investigation into the microflora of heroin. J Med Microbiol 2002; 51: 1001-1008.
23. National Drug Treatment Monitoring System. Statistics for drug treatment activity in England 2004/05. National Treatment Agency for Substance Misuse 2005. Available at: http://www.nta.nhs.uk/media/media_releases/2005_media_releases/ statistics_for_drug_treatment_activity_in_england_200405_stat_ release_211005.aspx (last accessed 15 November 2007)